Literature DB >> 24140048

A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?

M Stevenson1, N McNaughton.   

Abstract

Phenylketonuria (PKU) is a well-defined metabolic disorder arising from a mutation that disrupts phenylalanine metabolism and so produces a variety of neural changes indirectly. Severe cognitive impairment can be prevented by dietary treatment; however, residual symptoms may be reported. These residual symptoms appear to overlap a more prevalent childhood disorder: Attention Deficit/Hyperactivity Disorder (ADHD). However, the aetiology of ADHD is a vast contrast to PKU: it seems to arise from a complex combination of genes; and it has a substantial environmental component. We ask whether these two disorders result from two vastly different genotypes that converge on a specific core phenotype that includes similar dysfunctions of Gray's (Gray, 1982) Behavioural Inhibition System (BIS), coupled with other disorder-specific dysfunctions. If so, we believe comparison of the commonalities will allow greater understanding of the neuropsychology of both disorders. We review in detail the aetiology, treatment, neural pathology, cognitive deficits and electrophysiological abnormalities of PKU; and compare this with selected directly matching aspects of ADHD. The biochemical and neural pathologies of PKU and ADHD are quite distinct in their causes and detail; but they result in the disorder in the brain of large amino acid levels, dopamine and white matter that are very similar and could explain the overlap of symptoms within and between the PKU and ADHD spectra. The common deficits affect visual function, motor function, attention, working memory, planning, and inhibition. For each of PKU and ADHD separately, a subset of deficits has been attributed to a primary dysfunction of behavioural inhibition. In the case of ADHD (excluding the inattentive subtype) this has been proposed to involve a specific failure of the BIS; and we suggest that this is also true of PKU. This accounts for a substantial proportion of the parallels in the superficial symptoms of both disorders and we see this as linked to prefrontal, rather than more general, dysfunction of the BIS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Attention deficit hyperactivity disorder; BAEP; BH4; BIS; Behavioural Inhibition System; CRT; DAT1; DLPFC; DRD4; DTI; Dopamine; EEG; ERP; LNAA; MHP; MPF; MRI; PAH; PKU; Phe; Phenylketonuria; Prefrontal cortex; SSD; SSRT; SST; Trp; Tyr; VEP; White matter; attention deficit/hyperactivity disorders; brainstem auditory evoked potentials; choice reaction time; diffusion tensor imaging; dopamine receptor D4; dopamine transporter 1; dorsolateral prefrontal cortex; electroencephalography; event-related potentials; large neutral amino acid; magnetic resonance imaging; mean power frequency; mild-hyperphenylalaninemia; phenylalanine; phenylalanine hydroxylase; phenylketonuria; stop-signal delay; stop-signal reaction time; stop-signal task; tetrahydrobiopterin; tryptophan; tyrosine; visual evoked potentials

Mesh:

Substances:

Year:  2013        PMID: 24140048     DOI: 10.1016/j.brainresbull.2013.10.003

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

2.  Neurocognitive profiles in MSUD school-age patients.

Authors:  Juliette Bouchereau; Julie Leduc-Leballeur; Samia Pichard; Apolline Imbard; Jean-François Benoist; Marie-Thérèse Abi Warde; Jean-Baptiste Arnoux; Valérie Barbier; Anaïs Brassier; Pierre Broué; Aline Cano; Brigitte Chabrol; Gilles Damon; Claire Gay; Isabelle Guillain; Florence Habarou; Delphine Lamireau; Chris Ottolenghi; Laetitia Paermentier; Frédérique Sabourdy; Guy Touati; Hélène Ogier de Baulny; Pascale de Lonlay; Manuel Schiff
Journal:  J Inherit Metab Dis       Date:  2017-03-21       Impact factor: 4.982

Review 3.  Genetic etiology and clinical challenges of phenylketonuria.

Authors:  Nasser A Elhawary; Imad A AlJahdali; Iman S Abumansour; Ezzeldin N Elhawary; Nagwa Gaboon; Mohammed Dandini; Abdulelah Madkhali; Wafaa Alosaimi; Abdulmajeed Alzahrani; Fawzia Aljohani; Ehab M Melibary; Osama A Kensara
Journal:  Hum Genomics       Date:  2022-07-19       Impact factor: 6.481

4.  Some Metatheoretical Principles for Personality Neuroscience.

Authors:  Neil McNaughton; Luke D Smillie
Journal:  Personal Neurosci       Date:  2018-08-10

5.  Gut microbiome in ADHD and its relation to neural reward anticipation.

Authors:  Esther Aarts; Thomas H A Ederveen; Jilly Naaijen; Marcel P Zwiers; Jos Boekhorst; Harro M Timmerman; Sanne P Smeekens; Mihai G Netea; Jan K Buitelaar; Barbara Franke; Sacha A F T van Hijum; Alejandro Arias Vasquez
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

6.  Executive functioning, adaptive skills, emotional and behavioral profile: A comparison between autism spectrum disorder and phenylketonuria.

Authors:  Barbara Trimarco; Filippo Manti; Francesca Nardecchia; Sergio Melogno; Mara Testa; Giovanni Meledandri; Claudia Carducci; Roberta Penge; Vincenzo Leuzzi
Journal:  Mol Genet Metab Rep       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.